Renaissance Technologies’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.4M | Sell |
184,114
-9,500
| -5% | -$598K | 0.02% | 909 |
|
|
2025
Q4 | $10.8M | Sell |
193,614
-7,300
| -4% | -$423K | 0.02% | 875 |
|
|
2025
Q3 | $12.7M | Sell |
200,914
-12,400
| -6% | -$734K | 0.02% | 972 |
|
|
2025
Q2 | $12.1M | Sell |
213,314
-4,400
| -2% | -$239K | 0.02% | 954 |
|
|
2025
Q1 | $12.2M | Sell |
217,714
-3,796
| -2% | -$227K | 0.02% | 898 |
|
|
2024
Q4 | $13.6M | Sell |
221,510
-9,104
| -4% | -$589K | 0.02% | 828 |
|
|
2024
Q3 | $15.4M | Buy |
230,614
+3,500
| +2% | +$238K | 0.02% | 807 |
|
|
2024
Q2 | $15.2M | Sell |
227,114
-5,400
| -2% | -$368K | 0.03% | 718 |
|
|
2024
Q1 | $16.5M | Buy |
232,514
+27,900
| +14% | +$2.09M | 0.03% | 726 |
|
|
2023
Q4 | $17.2M | Sell |
204,614
-900
| -0.4% | -$74.6K | 0.03% | 671 |
|
|
2023
Q3 | $17.7M | Buy |
205,514
+2,122
| +1% | +$196K | 0.03% | 627 |
|
|
2023
Q2 | $19M | Sell |
203,392
-3,322
| -2% | -$313K | 0.03% | 703 |
|
|
2023
Q1 | $19.6M | Sell |
206,714
-3,900
| -2% | -$358K | 0.03% | 726 |
|
|
2022
Q4 | $21.2M | Sell |
210,614
-5,900
| -3% | -$539K | 0.03% | 684 |
|
|
2022
Q3 | $18.5M | Sell |
216,514
-10,856
| -5% | -$958K | 0.03% | 720 |
|
|
2022
Q2 | $19.5M | Buy |
227,370
+3,656
| +2% | +$312K | 0.02% | 742 |
|
|
2022
Q1 | $20.1M | Buy |
223,714
+800
| +0.4% | +$73.6K | 0.02% | 751 |
|
|
2021
Q4 | $22.3M | Sell |
222,914
-7,121
| -3% | -$727K | 0.03% | 652 |
|
|
2021
Q3 | $21.4M | Sell |
230,035
-13,879
| -6% | -$1.23M | 0.03% | 650 |
|
|
2021
Q2 | $20.7M | Sell |
243,914
-3,000
| -1% | -$260K | 0.03% | 741 |
|
|
2021
Q1 | $21.4M | Sell |
246,914
-823
| -0.3% | -$72.4K | 0.03% | 732 |
|
|
2020
Q4 | $20.9M | Buy |
247,737
+6,923
| +3% | +$590K | 0.02% | 732 |
|
|
2020
Q3 | $19.2M | Buy |
240,814
+7,100
| +3% | +$589K | 0.02% | 760 |
|
|
2020
Q2 | $20.7M | Buy |
233,714
+2,200
| +1% | +$197K | 0.02% | 797 |
|
|
2020
Q1 | $21.8M | Sell |
231,514
-2,700
| -1% | -$251K | 0.02% | 720 |
|
|
2019
Q4 | $25.3M | Sell |
234,214
-3,300
| -1% | -$334K | 0.02% | 881 |
|
|
2019
Q3 | $22.8M | Sell |
237,514
-11,000
| -4% | -$1.02M | 0.02% | 889 |
|
|
2019
Q2 | $23.8M | Buy |
248,514
+10,266
| +4% | +$864K | 0.02% | 870 |
|
|
2019
Q1 | $21M | Sell |
238,248
-966
| -0.4% | -$84.9K | 0.02% | 942 |
|
|
2018
Q4 | $19.9M | Sell |
239,214
-11,369
| -5% | -$1M | 0.02% | 888 |
|
|
2018
Q3 | $23.6M | Buy |
250,583
+24,283
| +11% | +$2.32M | 0.02% | 830 |
|
|
2018
Q2 | $24.9M | Buy |
226,300
+7,378
| +3% | +$770K | 0.03% | 794 |
|
|
2018
Q1 | $21.6M | Buy |
218,922
+6,722
| +3% | +$600K | 0.02% | 895 |
|
|
2017
Q4 | $17.3M | Buy |
212,200
+18,900
| +10% | +$1.48M | 0.02% | 1045 |
|
|
2017
Q3 | $14.2M | Buy |
193,300
+26,755
| +16% | +$1.92M | 0.02% | 1107 |
|
|
2017
Q2 | $12.1M | Buy |
166,545
+21,845
| +15% | +$1.44M | 0.02% | 1152 |
|
|
2017
Q1 | $9.02M | Buy |
144,700
+7,700
| +6% | +$485K | 0.01% | 1309 |
|
|
2016
Q4 | $9.97M | Buy |
137,000
+2,000
| +1% | +$130K | 0.02% | 1230 |
|
|
2016
Q3 | $8.07M | Buy |
135,000
+4,500
| +3% | +$286K | 0.01% | 1289 |
|
|
2016
Q2 | $8.22M | Buy |
130,500
+6,769
| +5% | +$437K | 0.02% | 1267 |
|
|
2016
Q1 | $7.74M | Buy |
123,731
+14,731
| +14% | +$869K | 0.01% | 1307 |
|
|
2015
Q4 | $6.38M | Buy |
109,000
+14,200
| +15% | +$805K | 0.01% | 1302 |
|
|
2015
Q3 | $5.11M | Buy |
94,800
+2,400
| +3% | +$131K | 0.01% | 1383 |
|
|
2015
Q2 | $5.51M | Buy |
92,400
+2,400
| +3% | +$135K | 0.01% | 1377 |
|
|
2015
Q1 | $5.39M | Buy |
90,000
+1,300
| +1% | +$76.4K | 0.01% | 1312 |
|
|
2014
Q4 | $5.33M | Buy |
88,700
+1,000
| +1% | +$55.4K | 0.01% | 1231 |
|
|
2014
Q3 | $4.28M | Buy |
87,700
+400
| +0.5% | +$20.3K | 0.01% | 1248 |
|
|
2014
Q2 | $4.49M | Buy |
87,300
+7,000
| +9% | +$359K | 0.01% | 1279 |
|
|
2014
Q1 | $4.64M | Buy |
80,300
+4,900
| +6% | +$267K | 0.01% | 1297 |
|
|
2013
Q4 | $4.31M | Buy |
75,400
+7,300
| +11% | +$400K | 0.01% | 1276 |
|
|
2013
Q3 | $4.05M | Buy |
68,100
+13,400
| +24% | +$731K | 0.01% | 1284 |
|
|
2013
Q2 | $2.97M | Buy |
+54,700
| New | +$2.58M | 0.01% | 1372 |
|
Other funds holding UTMD
BIP
VCM
MA
RHJA
Renaissance Technologies's UTMD Position: Q1 2026 in Review
Renaissance Technologies reduced its Utah Medical Products (UTMD) stake by 4.9% in Q1 2026, selling an estimated $598K and leaving 184,114 shares worth $11.4M. The position accounts for 0.02% of the portfolio, ranked #909.
Renaissance Technologies first reported a position in UTMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $25.3M in Q4 2019. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.
- Renaissance Technologies held 184,114 shares of Utah Medical Products worth $11.4M as of Q1 2026.
- Renaissance Technologies sold 9,500 Utah Medical Products shares in Q1 2026, an estimated $598K.
- Utah Medical Products made up 0.02% of Renaissance Technologies's portfolio in Q1 2026, its #909 holding.
- Renaissance Technologies first reported a position in Utah Medical Products in Q2 2013 and has held it in 52 quarters since.
- Renaissance Technologies's Utah Medical Products position peaked at $25.3M in Q4 2019.
- 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.